• Home
  • Products
    • Overview
    • Primary Antibodies
      • Overview
      • Anti-Allergen Antibodies
      • Anti-Virus Antibodies
      • Antibodies to Epitope Tags
      • Recombinant F4/80 Clone CI:A3-1
      • Recombinant Isotype Controls
      • Recombinant Antibodies derived from Human Patients
      • Recombinant Antibodies for In Vivo Research Use
      • Recombinant Antibodies for Immunotherapy Research
      • Research Grade Biosimilars
    • Recombinant Proteins
      • Overview
      • Fc Fusion Proteins
      • Immunoglobulin Fc domains (Ig Fc domains)
      • Multi-Tag Control Protein
      • Recombinant Free Light Chains
  • Custom Services
    • Overview
    • Antibody Engineering
      • Overview
      • Antibody Humanization
      • Bispecific and Trispecific Antibodies
    • Antibody Sequencing
      • Overview
      • Hybridoma Sequencing
      • Antibody Protein Sequencing
      • Polyclonal Antibody Sequencing
    • Antibody Expression
  • Assay Developers
  • About Us
    • Introduction
      • Overview
      • Our Management Team
      • Our Directors & Advisors
      • Why go recombinant?
      • Introductory Video
      • Testimonials
      • Antibody Applications
    • Core Technologies
      • Overview
      • Chimeric monoclonal antibodies (cAb)
      • Recombinant Non-IgG Isotypes
      • Fc Silent – Engineered Fc Domain
      • AbFab2 – recombinant F(ab)2 format
  • Antibody Resource
    • Overview
    • Antibody Overview
    • Antibody Engineering
    • Antibody Generation & Manufacturing
    • External Resources
  • Contact us
    • Contact Us
    • Meet Us
  • How to order
    • Direct order
    • Distributors
Clear all

Species Reactivity

-
  • H5N1 Influenza A Virus (5)

Applications

-
  • NTRL (5)
  • ELISA (2)
  • RIA (2)
£0.00
0 items
  • FAQs
United Kingdom (UK)
  • United States (US)
  • United Kingdom (UK)
  • Germany
  • Canada
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Gibraltar
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Monaco
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Other countries
£0.00
0 items
Menu
  • Home
  • Products
    • Overview
    • Primary Antibodies
      • Overview
      • Anti-Allergen Antibodies
      • Anti-Virus Antibodies
      • Antibodies to Epitope Tags
      • Recombinant F4/80 Clone CI:A3-1
      • Recombinant Isotype Controls
      • Recombinant Antibodies derived from Human Patients
      • Recombinant Antibodies for In Vivo Research Use
      • Recombinant Antibodies for Immunotherapy Research
      • Research Grade Biosimilars
    • Recombinant Proteins
      • Overview
      • Fc Fusion Proteins
      • Immunoglobulin Fc domains (Ig Fc domains)
      • Multi-Tag Control Protein
      • Recombinant Free Light Chains
  • Custom Services
    • Overview
    • Antibody Engineering
      • Overview
      • Antibody Humanization
      • Bispecific and Trispecific Antibodies
    • Antibody Sequencing
      • Overview
      • Hybridoma Sequencing
      • Antibody Protein Sequencing
      • Polyclonal Antibody Sequencing
    • Antibody Expression
  • Assay Developers
  • About Us
    • Introduction
      • Overview
      • Our Management Team
      • Our Directors & Advisors
      • Why go recombinant?
      • Introductory Video
      • Testimonials
      • Antibody Applications
    • Core Technologies
      • Overview
      • Chimeric monoclonal antibodies (cAb)
      • Recombinant Non-IgG Isotypes
      • Fc Silent – Engineered Fc Domain
      • AbFab2 – recombinant F(ab)2 format
  • Antibody Resource
    • Overview
    • Antibody Overview
    • Antibody Engineering
    • Antibody Generation & Manufacturing
    • External Resources
  • Contact us
    • Contact Us
    • Meet Us
  • How to order
    • Direct order
    • Distributors
HomePrimary AntibodiesRecombinant Antibodies derived from Human Patients

Recombinant Antibodies derived from Human Patients

Human antibodies from patients are being sequenced at an increasing rate – see Quake et al. for an up to date review of high throughput sequencing of antibodies. Amongst others, we are excited to offer you a range of human-derived antibodies specific to viral pathogens or self-antigen (many in collaboration with Humabs BioMed SA, Bellinzona, Switzerland). Our proprietary cloning platform allows us to produce high quality recombinant versions of these antibodies – we think some will be valuable reagents for research and diagnostics. We offer the original human IgG version as well as  a reformatted mouse and rabbit versions to suit your experimental requirements- contact us for bulk custom orders. For help on their applications see our application codes page.

Indirect immunofluorescence (IF) staining of live keratinocyte monolayers with pemphigus vulgaris auto-antibodies (A) Cryosections of human skin stained with biotinylated DSG3-specific monoclonal antibodies (Ab00153, Ab00155, Ab00158 and Ab00156). (B) Staining of human epidermis with biotinylated PVB28 (Ab00158) in the presence (with) or absence (w/o) of Ca2+. (C) Binding of a panel of pemphigus auto-antibodies to DSG3-coated ELISA plates in the presence or absence of EDTA.

Adjacent figure shows: Indirect immunofluorescence (IF) staining of live keratinocyte monolayers with pemphigus vulgaris (PV) auto-antibodies
(A) Cryosections of human skin stained with biotinylated DSG3-specific monoclonal antibodies (Ab00153, Ab00155, Ab00158 and Ab00156).
(B) Staining of human epidermis with biotinylated PVB28 (Ab00158) in the presence (with) or absence (w/o) of Ca2+.
(C) Binding of a panel of pemphigus auto-antibodies to DSG3-coated ELISA plates in the presence or absence of EDTA.Antibodies described in (external links): Corti D et al. 2010 as well as Di Zenzo G et al. 2012 

5
Products in this category:
Filter Results by... Filter Results
Clear all

Species Reactivity

-
  • H5N1 Influenza A Virus (5)

Applications

-
  • NTRL (5)
  • ELISA (2)
  • RIA (2)
Antibody Name [Clone]
Expected Species Reactivity
Applications
  • Anti-Influenza A HA [FLD127]
    H5N1 Influenza A Virus
    NTRL, RIA, ELISA
  • Anti-Influenza A HA [FLD20]
    H5N1 Influenza A Virus
    NTRL
  • Anti-Influenza A HA [FLD21]
    H5N1 Influenza A Virus
    NTRL
  • Anti-Influenza A HA [FLD84]
    H5N1 Influenza A Virus
    NTRL, RIA, ELISA
  • Anti-Influenza A HA [FLD93]
    H5N1 Influenza A Virus
    NTRL
Subscribe
Twitter
LinkedIn

Explore this site

Primary Antibodies
  • Anti-Allergen Antibodies
  • Anti-Virus Antibodies
  • Antibodies to Epitope Tags
  • Non-IgG Antibody Isotypes
  • Other products
  • Recombinant Antibodies derived from Human Patients
  • Recombinant Antibodies for Immunotherapy Research
  • Recombinant Antibodies for In Vivo Research Use
  • Recombinant F4/80 Clone CI:A3-1
  • Recombinant Isotype Controls
  • Research Grade Biosimilars
Recombinant Proteins
  • Fc Fusion Proteins
  • Immunoglobulin Fc domains (Ig Fc domains)
  • Multi-Tag Control Protein
  • Recombinant Free Light Chains

Copyright © 2019 Absolute Antibody. All rights reserved

  • Careers
  • Terms and Conditions
  • Privacy Policy

Website design by Electric Studio - Digital WordPress Agency Oxford